RA
MIRM icon

RiverPark Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

RiverPark Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Buy
2,865
+851
+42% +$85.4K 0.15% 73
2026
Q1 		$186K Buy
2,014
+282
+16% +$26.5K 0.07% 90
2025
Q4 		$137K Buy
1,732
+77
+5% +$5.53K 0.04% 101
2025
Q3 		$121K Buy
+1,655
New +$105K 0.05% 91

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RiverPark Advisors's MIRM Position: Q2 2026 in Review

RiverPark Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 42% in Q2 2026, buying an estimated $85.4K and bringing the position to 2,865 shares worth $335K. The position accounts for 0.15% of the portfolio, ranked #73.

RiverPark Advisors first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • RiverPark Advisors held 2,865 shares of Mirum Pharmaceuticals worth $335K as of Q2 2026.
  • RiverPark Advisors bought 851 Mirum Pharmaceuticals shares in Q2 2026, an estimated $85.4K.
  • Mirum Pharmaceuticals made up 0.15% of RiverPark Advisors's portfolio in Q2 2026, its #73 holding.
  • RiverPark Advisors first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on RiverPark Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.